2017;2:155 62. S4.3-41. DeFilippis AP, Young R, Carrubba CJ, et al. An analysis of calibra- tion and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort. Ann Intern Med. 2015;162:266 75. S4.3-42. Carr JJ, Jacobs DR Jr, Terry JG, et al. Association of coronary artery calcium in adults aged 32 to 46 years with incident coronary heart disease and death. JAMA Cardiol. 2017;2:391 9. S4.3-43. Fudim M, Zalawadiya S, Patel DK, et al. Data on coronary artery calcium score performance and cardiovascular risk reclassification across gender and ethnicities. Data Brief. 2016;6:578 81. S4.3-44. Gupta A, Lau E, Varshney R, et al. The identification of calcified coro- nary plaque is associated with initiation and continuation of pharma- cological and lifestyle preventive therapies: a systematic review and meta-analysis. JACC Cardiovasc Imaging. 2017;10:833 42. S4.3-45. Han D, Hartaigh B, Lee JH, et al. Assessment of coronary artery calcium scoring for statin treatment strategy according to ACC/ AHA guidelines in asymptomatic Korean adults. Yonsei Med J. 2017;58:82 9. S4.3-46. Hong JC, Blankstein R, Shaw LJ, et al. Implications of coronary artery calcium testing for treatment decisions among statin can- didates according to the ACC/AHA cholesterol management CLINICAL STATEMENTS AND GUIDELINES guidelines: a cost-effectiveness analysis. JACC Cardiovasc Imaging. 2017;10:938 52. S4.3-47. Kavousi M, Desai CS, Ayers C, et al. Prevalence and prognostic impli- cations of coronary artery calcification in low-risk women: a meta- analysis. JAMA. 2016;316:2126 34. S4.3-48. Mahabadi AA, M hlenkamp S, Lehmann N, et al. CAC score improves coronary and CV risk assessment above statin indication by ESC and AHA/ACC primary prevention guidelines. JACC Cardiovasc Imaging. 2017;10:143 53. S4.3-49. McClelland RL, Jorgensen NW, Budoff M, et al. 